NCT06647602 2026-02-10
THRIVE
University Medical Center Groningen
Not yet recruiting
Clinical Trials
11 trialsNCT04743661 2026-02-05
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Pediatric Brain Tumor Consortium
Phase 2 Active not recruiting
NCT07346157 2026-01-16
PNOC044
University of California, San Francisco
Phase 1/2 Not yet recruiting
NCT04782856 2024-06-14
Energy Metabolism in Thyroidectomized Patients
Virginia Commonwealth University
Phase 2 Completed
NCT00788307 2023-04-18
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy
Mayo Clinic
Phase 1 Terminated
NCT05017610 2022-12-02
Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
Emory University
Phase EARLY_PHASE1 Withdrawn
NCT01182285 2018-05-16
A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01360177 2016-07-20
Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers
Stanford University
Phase NA Withdrawn
NCT02785341 2016-05-27
APA2
Institut Paoli-Calmettes
Phase NA Terminated
NCT00223158 2014-04-09
Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer
Université de Sherbrooke
Phase NA Completed
NCT00004062 2013-12-19
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
National Cancer Institute (NCI)
Phase 1 Completed